Comprehensive, easy-to-understand information about this condition
How we create this content →Documentation on atrial septal defect, coronary sinus type, is limited primarily due to its rarity and the challenges in studying such uncommon conditions. Because it affects a small number of individuals, comprehensive clinical studies have been scarce. Additionally, the lack of identified genetic factors complicates the understanding of inheritance and phenotypic variability, leading to gaps in available information.
Key clinical features of atrial septal defect, coronary sinus type, include a left-to-right shunt (80-99% prevalence), which can cause significant hemodynamic changes. Patients may experience exertional dyspnea (30-79%), exercise intolerance (30-79%), and fatigue (30-79%). Additionally, some may present with a systolic heart murmur (30-79%) and palpitations (30-79%). Other associated anomalies may include anomalous pulmonary venous return and an abnormally loud second heart sound.
To navigate your care effectively, consider seeking a cardiologist with expertise in congenital heart defects, particularly those specializing in atrial septal defects. Additionally, participating in clinical trials may provide valuable insights and treatment options. For further resources, you can explore the Genetic and Rare Diseases Information Center at GARD (rarediseases.info.nih.gov) for potential support and information. Although no patient organizations are identified specifically for this condition, connecting with broader congenital heart defect communities may offer additional support.
Currently, there are no orphan drug designations for atrial septal defect, coronary sinus type. However, there is one active clinical trial available for this condition. You can find more details and eligibility criteria through the ClinicalTrials.gov search link: https://clinicaltrials.gov/search?cond=atrial%20septal%20defect%2C%20coronary%20sinus%20type. Participation in clinical trials may provide access to cutting-edge treatments and contribute to the understanding of this condition.
Actionable guidance for navigating care for atrial septal defect, coronary sinus type
To navigate your care effectively, consider seeking a cardiologist with expertise in congenital heart defects, particularly those specializing in atrial septal defects. Additionally, participating in clinical trials may provide valuable insights and treatment options. For further resources, you can explore the Genetic and Rare Diseases Information Center at GARD (rarediseases.info.nih.gov) for potential support and information. Although no patient organizations are identified specifically for this condition, connecting with broader congenital heart defect communities may offer additional support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation on atrial septal defect, coronary sinus type, is limited primarily due to its rarity and the challenges in studying such uncommon conditions. Because it affects a small number of individuals, comprehensive clinical studies have been scarce. Additionally, the lack of identified genetic factors complicates the understanding of inheritance and phenotypic variability, leading to gaps in available information.
Key clinical features of atrial septal defect, coronary sinus type, include a left-to-right shunt (80-99% prevalence), which can cause significant hemodynamic changes. Patients may experience exertional dyspnea (30-79%), exercise intolerance (30-79%), and fatigue (30-79%). Additionally, some may present with a systolic heart murmur (30-79%) and palpitations (30-79%). Other associated anomalies may include anomalous pulmonary venous return and an abnormally loud second heart sound.
To navigate your care effectively, consider seeking a cardiologist with expertise in congenital heart defects, particularly those specializing in atrial septal defects. Additionally, participating in clinical trials may provide valuable insights and treatment options. For further resources, you can explore the Genetic and Rare Diseases Information Center at GARD (rarediseases.info.nih.gov) for potential support and information. Although no patient organizations are identified specifically for this condition, connecting with broader congenital heart defect communities may offer additional support.
Currently, there are no orphan drug designations for atrial septal defect, coronary sinus type. However, there is one active clinical trial available for this condition. You can find more details and eligibility criteria through the ClinicalTrials.gov search link: https://clinicaltrials.gov/search?cond=atrial%20septal%20defect%2C%20coronary%20sinus%20type. Participation in clinical trials may provide access to cutting-edge treatments and contribute to the understanding of this condition.
Actionable guidance for navigating care for atrial septal defect, coronary sinus type
To navigate your care effectively, consider seeking a cardiologist with expertise in congenital heart defects, particularly those specializing in atrial septal defects. Additionally, participating in clinical trials may provide valuable insights and treatment options. For further resources, you can explore the Genetic and Rare Diseases Information Center at GARD (rarediseases.info.nih.gov) for potential support and information. Although no patient organizations are identified specifically for this condition, connecting with broader congenital heart defect communities may offer additional support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation on atrial septal defect, coronary sinus type, is limited primarily due to its rarity and the challenges in studying such uncommon conditions. Because it affects a small number of individuals, comprehensive clinical studies have been scarce. Additionally, the lack of identified genetic factors complicates the understanding of inheritance and phenotypic variability, leading to gaps in available information.
Key clinical features of atrial septal defect, coronary sinus type, include a left-to-right shunt (80-99% prevalence), which can cause significant hemodynamic changes. Patients may experience exertional dyspnea (30-79%), exercise intolerance (30-79%), and fatigue (30-79%). Additionally, some may present with a systolic heart murmur (30-79%) and palpitations (30-79%). Other associated anomalies may include anomalous pulmonary venous return and an abnormally loud second heart sound.
To navigate your care effectively, consider seeking a cardiologist with expertise in congenital heart defects, particularly those specializing in atrial septal defects. Additionally, participating in clinical trials may provide valuable insights and treatment options. For further resources, you can explore the Genetic and Rare Diseases Information Center at GARD (rarediseases.info.nih.gov) for potential support and information. Although no patient organizations are identified specifically for this condition, connecting with broader congenital heart defect communities may offer additional support.
Currently, there are no orphan drug designations for atrial septal defect, coronary sinus type. However, there is one active clinical trial available for this condition. You can find more details and eligibility criteria through the ClinicalTrials.gov search link: https://clinicaltrials.gov/search?cond=atrial%20septal%20defect%2C%20coronary%20sinus%20type. Participation in clinical trials may provide access to cutting-edge treatments and contribute to the understanding of this condition.
Actionable guidance for navigating care for atrial septal defect, coronary sinus type
To navigate your care effectively, consider seeking a cardiologist with expertise in congenital heart defects, particularly those specializing in atrial septal defects. Additionally, participating in clinical trials may provide valuable insights and treatment options. For further resources, you can explore the Genetic and Rare Diseases Information Center at GARD (rarediseases.info.nih.gov) for potential support and information. Although no patient organizations are identified specifically for this condition, connecting with broader congenital heart defect communities may offer additional support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.